Bit Bio
8 known investors
bit.bio is a synthetic biology company that engineers human induced pluripotent stem cells into defined cell types for research, drug discovery, and cell therapy applications. The company markets cells and disease models through its ioCells brand for use in biomedical research and therapeutic development.
Founders & leadership
DM
Dr Mark KotterFounder
PO
Przemek OblojCEO
Investors · 8
Companies House · registry record
View on Companies House ↗- Registered name
- BIT BIO LIMITED
- Company number
- 10466798
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 7 Nov 2016
- Registered office
- 3rd Floor 1 Ashley Road, Altrincham, Cheshire, WA14 2DT
- Nature of business (SIC)
- 72190 — Other research and experimental development on natural sciences and engineering
- Previous names
- ELPIS BIOMED LTD (2017–2019)CAMBRIDGE CELL TECHNOLOGIE LTD (2016–2017)
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 28 Feb 2026 · next due 14 Mar 2027
Current officers · 6
- Corneliu Chiriac — director, appointed 2 Dec 2024
- Mark Reinhard Kotter — director, appointed 7 Nov 2016
- Klevin Lo — director, appointed 18 Nov 2025
- David Prior — director, appointed 19 Jan 2026
- Emma Elizabeth Ward — director, appointed 29 Jun 2026
- Keying Xi — director, appointed 4 Nov 2024
Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.